Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study

• Melissa Mahoney,
• Frankie Ann Holmes,
• Benjamin Cho

Affiliations

Melissa Mahoney

Western University of Health Science-COMP NW, 200 Mullins Drive Lebanon, OR 97355, United States

Frankie Ann Holmes

Texas Oncology, US Oncology, Bellaire 77401-5507, TX, United States; Corresponding author.

Benjamin Cho

Willamette Valley Cancer Institute and Research Center, 520 Country Club Rd, Eugene 97401, OR, United States; Medical Oncology, Oregon Health and Science University Medical School, 840 S Gaines St, Portland 97239, OR, United States